Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation

Similar documents
A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer

ALAMEDA COUNTY BEHAVIORAL HEALTH CARE SERVICES MEDICATION FORMULARY

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers

Psychopharmacology of Autism Spectrum Disorder

4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies

Psychotropic Medication Use in Dementia

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX

Things You Might Not Know About Psychotropic Medications But Wish You Did

Tools that make a difference in mental health symptoms of autistic spectrum children Sumru Bilge-Johnson M.D. Program Director of Child Psychiatry

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

Disclosure Statement. A Rational Approach to Psychopharmacology. Goals 10/28/2013

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM. Autism Spectrum Disorder

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM

Psychiatric Medications. Positive and negative effects in the classroom

Guide to Psychiatric Medications for Children and Adolescents

Schedule FDA & literature based indications

An Overview on the Use of Psychotropic Medications

Pediatric Psychopharmacology

Introduction to Drug Treatment

Medications and Children Disorders

PSYCHIATRY DRUG ALERTS, VOLUME XXVIII, 2014 INDEX

Alpha-2 Agonists. Antipsychotics

Medications in Autism: What We Know and Don't Know

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX

Paediatric Psychopharmacology. Dr Jalpa Bhuta. MD, DNB, MRCPsych (UK).

What About Health 3: Challenging Behaviors

Using Drugs to Improve the Behavior of People with Autism: A Skeptical Appraisal. Alan Poling, Ph.D., BCBA-D Western Michigan University

Aggression (Severe) in Children under Age 6

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused

Psychiatry in Primary Care: What is the Role of Pharmacist?

Piecing the Puzzle Together: Pharmacologic Approaches to Behavioral Management in Autism Spectrum Disorder

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer

Augmentation and Combination Strategies in Antidepressants treatment of Depression

Mood Disorders.

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

Use of Psychotropic Medications in Older Adults with Dementia!

Mental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling

Disclosure. Objectives: Technician. Objectives: Pharmacist. Diagnostic and Statistical Manual (DSM-V) The Face of Mental Illness 7/25/2015

Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials

PSYCHIATRY INTAKE FORM

Medically Accepted Indications for Pediatric Use of Psychotropic Medications by

A Basic Approach to Mood and Anxiety Disorders in the Elderly

Psychotropic Drug Therapy in Adults with Learning Disability. Steve Wilkinson

11/2/2016 INSIDE THE MIND OF A CHILD PSYCHIATRIST: PROBLEM BEHAVIORS IN CHILDREN WITH AUTISM FACULTY DISCLOSURE

Clinical Guideline for the Management of Bipolar Disorder in Adults

Psychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis

Managing the Behavior Problems of Children With Fragile X Syndrome by Using Medication Ave M. Lachiewicz, MD, Duke University Medical Center

Medications in the School Setting. Kristen Nichols, PharmD, BCPS-AQ ID Butler University Riley Hospital for Children

Evidence-Based Pharmacotherapy. Emily Harris, MD, MPH, FAAP Cincinnati Children s Hospital Medical Center

Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment

Indications for Medications. John Wermager, MD May 2, 2017

Autism: Improving Health Care Outcomes

Atomoxetine. Open study showed 60% response of inattention and hyperactivity with a few much worse (Jou et al 2005)

Treatment of Autism Spectrum Disorder in Children and Adolescents

Objectives. Epidemiology. Diagnosis 3/27/2013. Identify positive and negative symptoms used for diagnosis of schizophrenia

MEDICATION ALGORITHM FOR ANXIETY DISORDERS

Objectives. Mental Health Info MEDICATION USE IN ASSISTED LIVING FACILITIES FOR MENTAL HEALTH ISSUES 11/12/2018

Depression. University of Illinois at Chicago College of Nursing

Antidepressants. Dr Malek Zihlif

Non-A, non-b=hcv; IFN/RBV; DSM-5/Ham-D, OLT; SSRI, P450

Promoting and Monitoring Evidenced-Based Antipsychotic Prescribing Practices in Children and Adolescents: Florida Medicaid Initiatives

NorthSTAR. Pharmacy Manual

Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder,

PL CE LIVE February 2011 Forum

10/7/16 ADHD: ASSESSMENT. Pharmacological Target Symptoms in Autism Spectrum Disorder (ASD) 1: REVIEW RATING SCALES AND RECORDS

11/11/2018. The ABCs of Medication Management for Autism Spectrum Disorder. ABC Logging (FBA) First. ABC Logging HOW TO COMPLEMENT BEHAVIORAL THERAPY

Manual of Clinical Psychopharmacology

For: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013

Too Many Meds? How to Prevent Polypharmacy in People with Intellectual/Developmental Disabilities

Depression in Older Adults. Paul Boulware, MD Arizona Neurological Institute April 22, 2012

VI.2 Elements for a public summary. VI.2.1 Overview of disease epidemiology

Antipsychotics. Something Old, Something New, Something Used to Treat the Blues

Jennifer Zarcone. Kennedy Krieger Institute and Johns Hopkins School of Medicine

FROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD OF ANXIETY

48 th Annual Meeting. Clinical Pearls: Depression, Insomnia and Bipolar Disorder DSM-5. Disclosure. Depression. Patient Case. Objectives 7/19/2014

PSYCHIATRY ALERTS CHILD& ADOLESCENT. Severe Mood Dysregulation or Bipolar Disorder?

Richard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA

Mentoring Session: Participant Cases

Anti-Depressant Medications

Antipsychotic Use in the Elderly

Pharmacological management in children and adolescents with pervasive developmental disorder

CONTRAINDICATIONS TABLE

Behavioral Health. Behavioral Health. Prescribing Guidelines

Attention Deficit Hyperactivity Disorder (ADHD) in Children under Age 6

Introductory discussion

2013 Virtual AD/HD Conference 1

To Give or not to Give Medication: That is the Question

Antidepressant Selection in Primary Care

Bipolar Disorder in Youth

Child & Adolescent Psychiatry (a brief overview)

Kelly Godecke, MD Department of Psychiatry University of Utah

Mental Health DNA Insight WHITE PAPER

ADHD Part II: Managing Comorbities

Pediatric Psychopharmacology: Erika Ryst, M.D. October 12, 2016

Major Depressive Disorder (MDD) in Children under Age 6

INDEX. Index. in this web service Cambridge University Press

Psychiatric Medication Guide

Eligible Beneficiaries

Transcription:

Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral Hospital for Children Nancy Lurie Marks Professor Harvard Medical School 1 Disclosure of Potential Conflicts None 2 Evaluation Diagnosis Clinical Characteristics and Genetic Testing Physical Examination Review of Systems Neuropsychological Testing Family History 3 1

Treatment Options Behavior therapy Speech and Language therapy Occupational therapy Physical therapy Social skills therapy Special educational services (academic vs. life skills track) Treatment of comorbid medical problems Vocational training Pharmacotherapy 4 Target Symptoms for Medication Motor hyperactivity and inattention Interfering repetitive thoughts and behavior Aggression, self injury, severe tantrums Depressive disorders Anxiety Sleep disturbance Inappropriate sexual behavior 5 Motor Hyperactivity and Inattention Psychostimulants: methylphenidate, dextroamphetamine Non stimulants: alpha 2 agonists guanfacine, clonidine, Intuniv; atomoxetine 6 2

Psychostimulants Work quickly Side effects: reduced appetite, insomnia, tics May cause behavioral worsening May need to be given multiple times per day Need new prescription each month (controlled substance) 7 Alpha-2 Agonists Need to monitor blood pressure and heart rate Can be sedating Generally don t make symptoms worse 2/3 need to be given 2 3 times per day Intuniv now FDA approved for ADHD in children 8 Atomoxetine Effective in ADHD; preliminary studies in developmental disabilities. May take longer to work than stimulants. May help with comorbid mood and/or anxiety. 9 3

Repetitive Thoughts and Behavior Selective Serotonin Reuptake Inhibitors (SSRIs) Fluoxetine Fluvoxamine Sertraline Paroxetine Citalopram (prolongation of the QT interval) Escitalopram (prolongation of the QT interval) 10 SSRIs (Cont d) Data indicate SSRIs may be more effective in post pubertal vs. pre pubertal individuals with developmental disabilities Side effects: insomnia, behavioral activation, sedation, stomach upset, sexual dysfunction, weight gain Can generally be given once a day Concern about increasing suicidal thinking/behavior 11 Aggression/Self-Injury/Severe Tantrums Typical antipsychotics Atypical antipsychotics Mood stabilizers 12 4

Aggression (Cont d) Typical Antipsychotics Haloperidol Thioridazine Chlorpromazine Side effects: acute extrapyramidal symptoms (EPS), tardive dyskinesia (TD), sedation, weight gain, drooling, prolongation of the QT interval 13 Aggression (Cont d) Atypical Antipsychotics Risperidone Aripiprazole Olanzapine Quetiapine Ziprasidone 14 Risperidone Well studied in autism (FDA approved) and intellectual disability associated with behavioral dyscontrol Common side effects: increased appetite, weight gain, sedation (transient), drooling, elevated prolactin 15 5

Aripiprazole FDA approved for irritability in children and adolescents with autism. Common side effects: EPS (akathisia) and nausea/vomiting if given at too high a starting dose. Occasionally transient sedation No prolactin elevation 16 Olanzapine Only small controlled studies in developmental disabilities Common side effects: increased appetite, weight gain (at times significant), has been associated with glucose and lipid dysregulation, sedation 17 Quetiapine No controlled studies in developmental disabilities Common side effects: increased appetite, weight gain (may be less prominent than with risperidone and olanzapine), sedation, orthostatic hypotension if dose increased too quickly 18 6

Ziprasidone No controlled studies in developmental disabilities Common side effects: sedation (transient), occasional insomnia or behavioral activation. Not associated with increased appetite or weight gain Should not be given to patients with cardiac problems without approval of cardiologist Must be taken with food 19 Aggression (Cont d) Mood Stabilizers Valproic acid Lithium Carbamazepine Gabapentin Topiramate Lamotrigine Generally ineffective unless true co morbid bipolar disorder 20 Depression Bupropion (risk of seizures) Venlafaxine (elevated blood pressure) Duloxetine SSRIs No systematic trials of medication for treating depression in Williams syndrome 21 7

Anxiety Buspirone Mirtazapine (weight gain, sedation) SSRIs (low dose) No systematic trials of medication for treating anxiety in Williams syndrome 22 Sleep Disturbance Melatonin Clonidine Trazodone (priapism) Mirtazapine Tricyclic Antidepressant (Doxepine, Amitriptyline) Chloral Hydrate Benzodiazepines (Paradoxical reaction) Diphenhydramine (Paradoxical reaction) 23 Inappropriate Sexual Behavior Behavioral strategies Sex education Mirtazapine SSRIs Hormonal strategies 24 8

Questions? 25 Lurie Center for Autism Williams Syndrome Neuropsychiatric Team Christopher J. McDougle, MD Barbara Pober, MD Christopher Keary, MD Lauren McGrath, PhD Jessica Waxler, MS Allison Hoffnagle, BA, BS Jennifer Mullett, RN, BSN http://www.massgeneral.org/children/services/ treatmentprograms 26 LURIE CENTER FOR AUTISM Christopher J. McDougle, M.D. CMCDOUGLE@PARTNERS.ORG (781) 860-1783 27 9